Search - tctmd.com

Displaying 1 - 20 of 30

Sort: Relevancy | Date

Presentation CTO 2026

Bioresorbable Scaffolds and Targeted Drug-Delivery in Chronic Total Occlusion Revascularization

Presenter: Nayana Bhandari

February 14, 2026

Presentation CTO 2026

Complete Staged Impella-Supported CHIP Revascularization of Dual CTOs and Critical LM–LAD Disease in Severe Ischemic Cardiomyopathy

Presenter: Qasim Jehangir

February 14, 2026

Presentation CTO 2026

Current Examples of Observational Studies in Coronary Revascularization – When to do a Single Arm Study and How to Analyze Large Datasets

Presenter: David J. Cohen

February 13, 2026

Presentation CTO 2026

Current Examples of Randomized Trials in Coronary Revascularization - Why Non-Inferiority and What is the WIN Ratio?

Presenter: David J. Cohen

February 13, 2026

Presentation CTO 2026

Safety and Technical Feasibility of a “Contrast-First” Strategy for Revascularization of Coronary Occlusions in Consecutive Patients

Presenter: Goutham Ravipati

February 13, 2026

Presentation CTO 2026

Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients Ineligible for Surgical Revascularization

Presenter: Joseph Park

February 13, 2026

Presentation CTO 2026

From OHCA to Complete CTO Revascularization

Presenter: Nirmal J. Kaur

February 13, 2026

Presentation CTO 2025

Procedural Impact of Advanced Calcific Plaque Modification Devices Within Percutaneous Revascularization of Chronic Total Occlusions Results From the European CTO Club Registry (ERCTO)

Presenter: Alfredo Galassi

March 01, 2025

Presentation CTO 2024

A Novel Surgical Approach to CTO Revascularization

Presenter: John D. Puskas

February 02, 2024

Presentation CTO 2023

Post CABG Revascularization – Pragmatic Graft Intervention or Native Vessel Reconstruction?

Presenter: Kevin J. Croce

February 24, 2023

Presentation CTO 2023

How Do the Coronary Revascularization Clinical Trials Apply to the Patient in Front of Me?

Presenter: Ajay Kirtane

February 23, 2023

Presentation CTO 2022

How Complete Does Complete Revascularization Really Need to Be?

Presenter: J. Aaron Grantham

February 25, 2022

Presentation CTO 2022

Surgical Turndowns: What We Know and What We Don’t

Presenter: David Kandzari

February 25, 2022

Presentation CTO 2022

Is CABG Really the Best Primary Approach to Multivessel/LMCA Disease? Interventional Perspectives

Presenter: Gregg Stone

February 25, 2022

Presentation CTO 2022

Is CABG Really the Best Primary Approach to Multivessel/LMCA Disease? A Surgeon’s Viewpoint

Presenter: Mario Gaudino

February 25, 2022

Presentation CTO 2022

Debate 1: Complete Revascularization - Pedantic Dogma versus Complete Revascularization - Anything Less is Sloppy

Presenter: Akshay Bagai

February 24, 2022

Presentation CTO 2022

Debate 1: Complete Revascularization - Pedantic Dogma versus Complete Revascularization - Anything Less is Sloppy

Presenter: Kathleen Kearney

February 24, 2022

Presentation CTO 2022

CTO and Complex PCI in the Revascularization Guidelines: What Were They Thinking?

Presenter: Ajay Kirtane

February 24, 2022

Presentation CTO 2017

CTO PCI in Patients With Multivessel and Left Main Disease/Concepts of Optimal Revascularization

Presenter: Emmanouil S. Brilakis, Gerald S. Werner, Robert W. Yeh

February 23, 2017

Presentation CTO 2014

Left Main Lesion Assessment Before Revascularization: Intravascular Ultrasound Should Remain the Standard!

Presenter: Gary S. Mintz

March 01, 2014

Advertisement

Bioresorbable Scaffolds and Targeted Drug-Delivery in Chronic Total Occlusion Revascularization

Complete Staged Impella-Supported CHIP Revascularization of Dual CTOs and Critical LM–LAD Disease in Severe Ischemic Cardiomyopathy

Current Examples of Observational Studies in Coronary Revascularization – When to do a Single Arm Study and How to Analyze Large Datasets

Current Examples of Randomized Trials in Coronary Revascularization - Why Non-Inferiority and What is the WIN Ratio?

Safety and Technical Feasibility of a “Contrast-First” Strategy for Revascularization of Coronary Occlusions in Consecutive Patients

Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients Ineligible for Surgical Revascularization

From OHCA to Complete CTO Revascularization

Procedural Impact of Advanced Calcific Plaque Modification Devices Within Percutaneous Revascularization of Chronic Total Occlusions Results From the European CTO Club Registry (ERCTO)

A Novel Surgical Approach to CTO Revascularization

Post CABG Revascularization – Pragmatic Graft Intervention or Native Vessel Reconstruction?

How Do the Coronary Revascularization Clinical Trials Apply to the Patient in Front of Me?

How Complete Does Complete Revascularization Really Need to Be?

Surgical Turndowns: What We Know and What We Don’t

Is CABG Really the Best Primary Approach to Multivessel/LMCA Disease? Interventional Perspectives

Is CABG Really the Best Primary Approach to Multivessel/LMCA Disease? A Surgeon’s Viewpoint

Debate 1: Complete Revascularization - Pedantic Dogma versus Complete Revascularization - Anything Less is Sloppy

Debate 1: Complete Revascularization - Pedantic Dogma versus Complete Revascularization - Anything Less is Sloppy

CTO and Complex PCI in the Revascularization Guidelines: What Were They Thinking?

CTO PCI in Patients With Multivessel and Left Main Disease/Concepts of Optimal Revascularization

Left Main Lesion Assessment Before Revascularization: Intravascular Ultrasound Should Remain the Standard!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content